tiprankstipranks
Extendicare (TSE:EXE)
TSX:EXE

Extendicare (EXE) AI Stock Analysis

Compare
184 Followers

Top Page

TS

Extendicare

(TSX:EXE)

74Outperform
Extendicare demonstrates strong financial growth, effective cash management, and strategic focus on expansion. Despite operational efficiency challenges and high leverage, the company benefits from positive earnings sentiment and solid dividend returns. Technical indicators suggest short-term caution, but overall, the stock presents a compelling value proposition for investors.
Positive Factors
Demographics
EXE is expected to benefit from aging demographics and a sizable LTC waitlist in Ontario, which should drive demand tailwinds.
Financial Flexibility
A conservative financial profile with low debt ratios provides flexibility and potential for future acquisition activity.
Operating Metrics
Strong improvements in operating metrics within the LTC and home health businesses have led to leading price performance amongst Canadian seniors.
Negative Factors
Analyst Rating
Analyst's neutral rating reflects higher total returns expected elsewhere and a current preference for private-pay retirement residences.
Market Preference
Despite the positive aspects, there is currently a preference for companies with exposure to private-pay retirement residences.

Extendicare (EXE) vs. S&P 500 (SPY)

Extendicare Business Overview & Revenue Model

Company DescriptionExtendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.
How the Company Makes MoneyExtendicare generates revenue through several key streams. The primary source of income is its long-term care services, where the company receives funding from provincial governments for providing personal and medical care to residents in its facilities. Additionally, Extendicare earns from its home health care segment by offering nursing and personal support services to clients in their homes, funded through a combination of government contracts and private pay clients. The retirement living segment also contributes to revenue through rental income from its various retirement communities. Furthermore, Extendicare engages in strategic partnerships and alliances to enhance service delivery and optimize operational efficiencies, which can lead to cost savings and additional revenue opportunities.

Extendicare Financial Statement Overview

Summary
Extendicare exhibits strong revenue growth and improving net income margins, supported by effective cash flow generation. However, the company faces challenges with operational efficiency and high leverage. While the balance sheet reflects significant debt usage, the improved return on equity and positive cash flow trends are favorable indicators of financial health.
Income Statement
75
Positive
Extendicare has demonstrated strong revenue growth with a 12.39% increase from 2023 to 2024. The gross profit margin is robust at 100% for 2024 due to the accounting treatment, while the net profit margin improved significantly to 5.13% from 2.60% in 2023. The EBIT margin dropped to 0% in 2024, indicating operational challenges despite the revenue increase. Overall, profitability is improving but operational efficiency requires attention.
Balance Sheet
60
Neutral
The company's debt-to-equity ratio remains high at 2.35, indicating significant leverage, although it has decreased from previous years. The return on equity has improved to 60.49% in 2024, showing better utilization of equity for generating profits. However, the equity ratio of 17.28% suggests a relatively low equity base compared to total assets, indicating a reliance on debt financing.
Cash Flow
80
Positive
Extendicare's free cash flow has turned positive in 2024, growing from a negative figure in 2023 to a strong positive figure, indicating improved cash generation. The operating cash flow to net income ratio is 1.91, showing efficient cash conversion from earnings. The free cash flow to net income ratio is 1.35, further reinforcing effective cash flow management.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
1.47B1.30B1.22B1.22B1.16B
Gross Profit
1.47B118.43M76.83M151.72M197.69M
EBIT
0.0062.96M20.99M56.62M93.30M
EBITDA
155.27M98.63M48.90M67.46M125.08M
Net Income Common Stockholders
75.21M33.98M-4.51M9.01M42.59M
Balance SheetCash, Cash Equivalents and Short-Term Investments
121.85M75.91M167.28M104.63M179.96M
Total Assets
719.79M672.73M781.58M900.32M963.13M
Total Debt
292.49M334.52M383.97M536.85M564.60M
Net Debt
170.64M259.33M216.69M432.22M384.64M
Total Liabilities
595.44M584.81M680.88M798.40M834.94M
Stockholders Equity
124.35M87.92M100.70M101.92M128.19M
Cash FlowFree Cash Flow
101.69M-106.13M-2.92M-6.10M88.17M
Operating Cash Flow
143.64M23.28M98.71M63.42M121.27M
Investing Cash Flow
-9.11M-84.45M155.64M-63.73M2.00M
Financing Cash Flow
-87.87M-30.93M-191.86M-74.84M-38.16M

Extendicare Technical Analysis

Technical Analysis Sentiment
Positive
Last Price13.05
Price Trends
50DMA
11.90
Positive
100DMA
11.03
Positive
200DMA
9.62
Positive
Market Momentum
MACD
0.32
Positive
RSI
65.84
Neutral
STOCH
36.47
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:EXE, the sentiment is Positive. The current price of 13.05 is above the 20-day moving average (MA) of 13.00, above the 50-day MA of 11.90, and above the 200-day MA of 9.62, indicating a bullish trend. The MACD of 0.32 indicates Positive momentum. The RSI at 65.84 is Neutral, neither overbought nor oversold. The STOCH value of 36.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:EXE.

Extendicare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (48)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSEXE
74
Outperform
C$1.09B14.5670.86%3.69%12.36%123.26%
TSSIA
61
Neutral
C$1.54B33.298.99%5.58%13.72%429.22%
TSKPT
59
Neutral
C$77.95M31.983.53%9.08%
48
Neutral
$6.86B1.11-50.22%2.47%16.71%1.53%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:EXE
Extendicare
13.05
6.14
88.86%
TSE:KPT
KP Tissue
7.93
-0.09
-1.12%
TSE:SIA
Sienna Senior Living
16.76
4.39
35.49%
MFCSF
Medical Facilities
11.63
4.07
53.84%

Extendicare Earnings Call Summary

Earnings Call Date: Feb 27, 2025 | % Change Since: 12.99% | Next Earnings Date: May 6, 2025
Earnings Call Sentiment Positive
The earnings call highlights Extendicare's strong financial performance with significant growth in adjusted EBITDA, home healthcare services, and managed services. The company also benefits from increased government funding and has announced a dividend increase. Challenges include potential impacts of tariffs and inflation on construction costs and the termination of management agreements due to Revera's asset sales. Overall, the positive aspects significantly outweigh the challenges.
Highlights
Significant Increase in Adjusted EBITDA
Adjusted EBITDA excluding out-of-period items increased by 43.5% to $33.4 million, indicating strong operational performance.
Home Healthcare Growth
Delivered a record 11 million hours of care in 2024, with Q4 showing a 10.1% increase in average daily volume from the prior year period.
Ontario Government Funding Increase
4% rate increase for the home care sector retroactive to April 1, 2024, supporting compensation, recruitment, retention, and technology investments.
Expansion Achievements
Opened a new home in Kingston with 192 beds and another 256 beds in Stittsville, Ontario, contributing to strong results in the managed services segment.
Dividend Increase
Announced a 5% increase in the common share dividend to $0.042 per month, reflecting financial strength and growth potential.
Lowlights
Impact of Inflation and Tariffs on Construction Costs
Potential impact on construction costs due to tariffs and inflation, though current leveling off was noted; government funding programs may need adjustments.
Termination of Management Agreements
Revera announced the sale of 21 Class C homes managed by Extendicare, resulting in the termination of management agreements for 30 homes.
Company Guidance
During Extendicare Inc.'s fourth-quarter 2024 analyst conference call, the company provided extensive guidance on its financial performance and strategic initiatives. The adjusted EBITDA, excluding out-of-period items, increased by 43.5% to $33.4 million, reflecting strong performance across various segments. The long-term care segment saw a 150 basis point increase in Q4 NOI margins, while the home healthcare segment delivered a record 11 million hours of care, with a 10.1% increase in average daily volume and a 160 basis point margin improvement. Extendicare also expanded its managed services, adding new beds in Kingston and Stittsville, contributing to a 7.4% year-over-year growth in bed services. The company maintained its managed service margins within the 50% to 55% target range and announced a 5% dividend increase, supported by a dividend payout ratio of less than 50% for 2024. Additionally, Extendicare outlined its strategic focus on redevelopment projects and acquisitions, with plans to redevelop 361 long-term care beds and a projected increase in annual NOI of $6.8 million and AFFO of $1.4 million. The company's strong liquidity position, with cash on hand of $122 million and access to $108 million under a new credit facility, positions it well for future growth.

Extendicare Corporate Events

Dividends
Extendicare Declares March 2025 Dividend
Positive
Mar 17, 2025

Extendicare Inc. has declared a cash dividend of C$0.042 per common share for March 2025, payable on April 15, 2025, to shareholders of record as of March 31, 2025. This announcement reflects Extendicare’s ongoing commitment to providing returns to its shareholders while maintaining its focus on delivering quality care services across Canada. The dividend designation as an ‘eligible dividend’ under the Income Tax Act (Canada) may have favorable tax implications for shareholders.

M&A TransactionsDividendsBusiness Operations and StrategyFinancial Disclosures
Extendicare Reports Strong Q4 2024 Results and Announces Dividend Increase
Positive
Feb 27, 2025

Extendicare reported a significant increase in adjusted EBITDA for the fourth quarter of 2024, driven by improvements across all business segments. The company completed several strategic initiatives, including acquiring LTC homes from Revera Inc., opening new facilities, and redeeming convertible debentures, which strengthened its financial position. The company also announced a 5% increase in its monthly dividend, reflecting its improved performance and growth prospects.

Executive/Board Changes
Extendicare Announces Board of Directors Changes
Neutral
Feb 27, 2025

Extendicare Inc., a company listed on the Toronto Stock Exchange, has announced changes to its board of directors. Donald Clow and Heather-Anne Irwin have been appointed to the board, replacing Al Mawani who is retiring after seven years of service. These appointments bring the board back to nine directors. Clow brings extensive experience in the real estate sector, having held executive roles at Crombie REIT and other organizations, while Irwin has a strong background in finance and capital markets, currently serving on the boards of Artis REIT and the Ontario Financing Authority.

DividendsBusiness Operations and Strategy
Extendicare Declares February 2025 Dividend, Reinforcing Shareholder Value
Positive
Feb 14, 2025

Extendicare Inc. has announced a C$0.04 cash dividend per common share for February 2025, payable on March 17, 2025, to shareholders recorded by February 28, 2025. This announcement signifies the company’s ongoing commitment to providing shareholder value and reflects its stable financial standing. The dividend, characterized as an ‘eligible dividend’ under Canadian tax law, underscores Extendicare’s strategic focus on maintaining consistent returns for investors while continuing to support the growing needs of the senior population through its extensive care and service operations.

Extendicare Declares C$0.04 January Dividend, Strengthening Investor Returns
Jan 15, 2025

Extendicare Inc. has declared a cash dividend of C$0.04 per common share for January 2025, payable to shareholders on February 14, 2025. This announcement reflects the company’s commitment to providing regular returns to its investors, reinforcing Extendicare’s stable financial strategy amidst its ongoing dedication to senior care services in Canada.

Extendicare to Release 2024 Q4 Financial Results and Host Conference Call
Jan 13, 2025

Extendicare has announced the release of its fourth quarter 2024 financial results on February 27, 2025, followed by a conference call on February 28, 2025, to discuss the outcomes. This announcement is significant as it provides stakeholders with insights into the company’s financial performance and operational strategies, reinforcing its commitment to transparency and stakeholder engagement.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.